| Oct 12 |
AstraZeneca PLC (AZN): A Top Holding in George Soros’s Portfolio
|
| Oct 9 |
Astrazeneca (AZN) Loses -5.29% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
|
| Oct 8 |
AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline
|
| Oct 8 |
Want to Invest in the Weight Loss Boom? Consider Buying These 2 Stocks
|
| Oct 8 |
AstraZeneca’s Phase III trial of treatment for asthma meets its primary endpoint
|
| Oct 8 |
Zacks Industry Outlook Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer
|
| Oct 7 |
AstraZeneca reports positive results for Airsupra v. albuterol study
|
| Oct 7 |
5 Large Drug Stocks to Watch From a Thriving Industry
|
| Oct 7 |
AstraZeneca Inks $1.92B License Pact With Hong Kong-Based Firm To Boost Cardiovascular Pipeline
|
| Oct 7 |
AIRSUPRA® (albuterol/budesonide) demonstrated statistically significant and clinically meaningful reduction in the risk of severe exacerbations in patients with intermittent or mild persistent asthma in BATURA Phase III trial
|
